| Class 2 Device Recall Renasys EZ |  |
Date Initiated by Firm | November 14, 2013 |
Date Posted | February 21, 2014 |
Recall Status1 |
Terminated 3 on August 04, 2014 |
Recall Number | Z-1067-2014 |
Recall Event ID |
66893 |
Product Classification |
wound therapy system - Product Code OMP
|
Product | Renasys EZ, a Canister Component of of Renasys EZ Negative Pressure Wound Therapy System |
Code Information |
Product code: 66800912 - 800ml canister with solidifier 66800913 - 250ml canister with solidifier 66801066 - 800ml canister without solidifier 66800423 - 800ml canister with solidifier 66800058 - 250ml canister with solidifier Lot codes - M201498 thru M400299 |
Recalling Firm/ Manufacturer |
Smith & Nephew Inc. 970 Lake Carillon Dr Ste 110 Saint Petersburg FL 33716-1130
|
For Additional Information Contact | Customer Care Department 800-876-1261 |
Manufacturer Reason for Recall | Modification of the bacterial overflow guard (filter) and related changes to product labeling. |
FDA Determined Cause 2 | Device Design |
Action | The correction strategy is as follows:
" An Urgent Medical Device Correction Notice has been prepared to be distributed to all US consignees via Federal Express delivery for confirmation of the delivery.
" A copy of the Urgent Medical Device Correction Notice is to be posted on Smith & Nephew's websites, URL corporate, http://www.smith-nephew.com/news-and-media/, and myrenasys.com, concurrent with the distribution of the Notice to consignees.
" US distribution of the original design of Canister Kits codes (66800912, 66800913, 66801066, 66800423 and 66800058) subject to this correction ceased November 1, 2013.
" The correction has been implemented on a change being affected basis. The modified design is being distributed to US customers effective November 1, 2013. No product will be removed from the market.
" Periodic progress reports to FDA, as required per 21 CFR 806 will be submitted monthly until completion of the correction actions.. |
Quantity in Commerce | 6,799,140 canisters EZ & EZ PLUS |
Distribution | Worldwide Distribution: USA (nationwide) including states of: AL, AZ, CA, CO, CT, FL, GA, HI, IA, IL, IN, KY, LA, MA, MI, MN, MO, MS, MT, NC, NH, NV, NY, OH, OR, PA, RI, SC, SD, TN, TX, VA, WA, WV, and Puerto Rico; and the countries of: Austria, Australia, Belgium, Switzerland, China, Cyprus, Germany, Denmark, Spain, Finland, France, UK, Greece, Israel, Italy, Malta, Netherlands, Norway, Paraguay, Russia, Saudi Arabia, Sweden, Thailand, Turkey, South Africa, Mexico, and Canada. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|